Inducing CTLA-4–Dependent Immune Regulation by Selective CD28 Blockade Promotes Regulatory T Cells in Organ Transplantation
2010 · Science Translational Medicine · 159 citations
https://doi.org/10.1126/scitranslmed.3000116
B
Bernard Vanhove
Hôpital Foch(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
189
Papers
4.7K
Citations
38
h-index
90
i10-index
Bernard Vanhove is an academic researcher from Hôpital Foch. The author has contributed to research in topics: T-cell and B-cell Immunology & Immune Cell Function and Interaction & Immunotherapy and Immune Responses. The author has an h-index of 38, co-authored 161 publications.
ORCID: 0000-0002-2872-8648Papers by this author
worksFR104, an Antagonist Anti-CD28 Monovalent Fab’ Antibody, Prevents Alloimmunization and Allows Calcineurin Inhibitor Minimization in Nonhuman Primate Renal Allograft
2014 · American Journal of Transplantation · 84 citations
https://doi.org/10.1111/ajt.12964
Preclinical Efficacy and Immunological Safety of FR104, an Antagonist Anti-CD28 Monovalent Fab′ Antibody
2012 · American Journal of Transplantation · 74 citations
https://doi.org/10.1111/j.1600-6143.2012.04164.x
First-in-Human Study in Healthy Subjects with FR104, a Pegylated Monoclonal Antibody Fragment Antagonist of CD28
2016 · The Journal of Immunology · 60 citations
https://doi.org/10.4049/jimmunol.1601538
Selective blockade of CD28 on human T cells facilitates regulation of alloimmune responses
2017 · JCI Insight · 40 citations
https://doi.org/10.1172/jci.insight.89381
T Cell Repertoire Alterations of Vascularized Xenografts
1999 · The Journal of Immunology · 37 citations
https://doi.org/10.4049/jimmunol.162.6.3367
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat